Senhwa Biosciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 0.15 million compared to TWD 0.15 million a year ago. Net loss was TWD 87.16 million compared to TWD 117.99 million a year ago. Basic loss per share from continuing operations was TWD 0.97 compared to TWD 1.52 a year ago. Diluted loss per share from continuing operations was TWD 0.97 compared to TWD 1.52 a year ago. Basic loss per share was TWD 0.97 compared to TWD 1.52 a year ago. Diluted loss per share was TWD 0.97 compared to TWD 1.52 a year ago. For the nine months, sales was TWD 0.45 million compared to TWD 0.467 million a year ago. Net loss was TWD 246.72 million compared to TWD 273.99 million a year ago. Basic loss per share from continuing operations was TWD 2.75 compared to TWD 3.63 a year ago. Diluted loss per share from continuing operations was TWD 2.75 compared to TWD 3.63 a year ago. Basic loss per share was TWD 2.75 compared to TWD 3.63 a year ago. Diluted loss per share was TWD 2.75 compared to TWD 3.63 a year ago.